Our Drug Candidate Could Halt the Progression of Parkinson’s
Patients diagnosed with Parkinson’s disease are faced with a difficult truth: there’s nothing they can do to keep their condition from worsening. KM-819 changes that—slowing and even stopping the progression of neurodegenerative conditions like PD and multiple system atrophy.
See the unique mechanism we use to
stop the progression of neurodegenerative conditions and the drug’s current phase in clinical development.
the FAScinate team behind the development of KM-819.
Want to become
an investment or development partner?
Click here to reach out.